Association of Serum Selenium Levels with the Response to Erythropoiesis-Stimulating Agents in Maintenance Hemodialysis Patients

被引：0
|
作者：
Yasukawa, Minoru [1 ]
Arai, Shigeyuki [1 ]
Nagura, Michito [1 ]
Hirohama, Daigoro [1 ]
Yamazaki, Osamu [1 ]
Tamura, Yoshifuru [1 ]
Fujigaki, Yoshihide [1 ]
Shibata, Shigeru [1 ]
机构：
[1] Teikyo Daigaku Igakubu Daigakuin Igaku Kenkyuka, Itabashi Ku, Tokyo, Japan
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2021年 / 32卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PO1744
引用
收藏
页码：540 / 541
页数：2
相关论文
共 50 条
  • [41] Predictors of response to erythropoiesis-stimulating agents (ESA) in cancer patients: the role of baseline serum epoetin level
    Jaime Sanz Ortiz
    Clinical and Translational Oncology, 2008, 10 : 486 - 492
  • [42] Association of a Change in Erythropoiesis-Stimulating Agent Dose During Hospitalization and Subsequent Hemoglobin Levels and Transfusions in Hemodialysis Patients
    Wong, Ben C.
    Ravani, Pietro
    Manns, Braden J.
    Lewin, Adriane
    Zhang, Xin
    Chin, Rick
    Hemmelgarn, Brenda R.
    Tonelli, Marcello
    Oliver, Matthew J.
    Quinn, Robert R.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2013, 62 (05) : 947 - 952
  • [43] Association of plasma F2-isoprostanes and isofurans concentrations with erythropoiesis-stimulating agent resistance in maintenance hemodialysis patients
    Rivara, Matthew B.
    Ikizler, T. Alp
    Ellis, Charles D.
    Mehrotra, Rajnish
    Himmelfarb, Jonathan
    BMC NEPHROLOGY, 2015, 16
  • [44] Association of the erythropoiesis-stimulating agent resistance index and the geriatric nutritional risk index with cardiovascular mortality in maintenance hemodialysis patients
    Yajima, Takahiro
    Yajima, Kumiko
    Takahashi, Hiroshi
    PLOS ONE, 2021, 16 (01):
  • [45] Association of plasma F2-isoprostanes and isofurans concentrations with erythropoiesis-stimulating agent resistance in maintenance hemodialysis patients
    Matthew B. Rivara
    T. Alp Ikizler
    Charles D. Ellis
    Rajnish Mehrotra
    Jonathan Himmelfarb
    BMC Nephrology, 16
  • [46] Confusion about the Appropriate Use of Erythropoiesis-Stimulating Agents in Patients Undergoing Maintenance Dialysis
    Winkelmayer, Wolfgang C.
    SEMINARS IN DIALYSIS, 2010, 23 (05) : 486 - 491
  • [47] Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents
    Tessitore, Nicola
    Girelli, Domenico
    Campostrini, Natascia
    Bedogna, Valeria
    Solero, Giovanni Pietro
    Castagna, Annalisa
    Melilli, Edoardo
    Mantovani, William
    De Matteis, Giovanna
    Olivieri, Oliviero
    Poli, Albino
    Lupo, Antonio
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (12) : 3996 - 4002
  • [48] Lower serum magnesium level is an important risk factor for erythropoiesis-stimulating agents hypo-responsiveness in hemodialysis patients
    Hebah, Hayam
    Abdelmegied, Shaimaa
    Osman, Dina
    Khedr, Lina
    EGYPTIAN JOURNAL OF INTERNAL MEDICINE, 2025, 37 (01):
  • [49] ERYTHROPOIESIS-STIMULATING AGENTS AND THROMBOTIC EVENTS IN DIALYSIS PATIENTS
    Suttorp, Marit M.
    Hoekstra, Tiny
    Ocak, Gurbey
    Van Diepen, Anouk T. N.
    Ott, Ilka
    Mittelman, Moshe
    Rabelink, Ton J.
    Krediet, Raymond T.
    Dekker, Friedo W.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 233 - 233
  • [50] Erythropoiesis-stimulating agents and thrombotic events in dialysis patients
    Suttorp, Marit M.
    Hoekstra, Tiny
    Ocak, Gurbey
    van Diepen, Anouk T. N.
    Ott, Ilka
    Mittelman, Moshe
    Rabelink, Ton J.
    Krediet, Raymond T.
    Dekker, Friedo W.
    THROMBOSIS RESEARCH, 2014, 134 (05) : 1081 - 1086
12345